Duke University: Cigarette Smoking trials

The registry lists 27 Cigarette Smoking studies with Duke University as lead sponsor. 0 are open to participants now and 15 have results posted.

Phase 1 3Phase 2 8Phase 3 4Phase 4 3No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Low Nicotine Cigarettes, Smoking, and Chronic PainCompletedNCT05032755Not applicableResults posted
• The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion ProductsCompletedNCT03492463Phase 2Results posted
• Effects of Smoking Environments on Brain ReactivityCompletedNCT03421210Phase 4Results posted
• Neurobehavioral Substrates of Propranolol's Effects on Drug Cue ReactivityCompletedNCT03309943Phase 4Results posted
• Combination Nicotine Patch / Lorcaserin for Smoking CessationCompletedNCT02906644Phase 2Results posted
• Mobile Contingency Management for Marijuana and Tobacco CessationCompletedNCT02869451Not applicableResults posted
• Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)CompletedNCT02551692Not applicableResults posted
• Adaptive Pharmacotherapy for Smoking CessationCompletedNCT02501265Phase 2Results posted
• Mobile Health Technology to Enhance Abstinence in Smokers With SchizophreniaCompletedNCT02420015Phase 4Results posted
• Combination Bupropion / Varenicline for Smoking Cessation in Male SmokersCompletedNCT01806779Phase 2Results posted
• Tailored Smoking Cessation Treatment for LIVE FOR LIFE® ParticipantsTerminatedNCT01560507Phase 2/3Results posted
• Meclizine as a Potential Smoking Cessation TreatmentCompletedNCT01443858Phase 2Results posted
• Mechanistic Evaluations of Pre-Cessation Therapies for Smoking CessationCompletedNCT01406223Phase 3Results posted
• Concurrent Bupropion / Varenicline for Smoking CessationCompletedNCT01303861Phase 3Results posted
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation IICompletedNCT00734617Phase 3Results posted
• Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2CompletedNCT05473585Not applicable
• Impact of New Product Standards for JUUL Among Dual JUUL/Combusted Cigarette UsersWithdrawnNCT04179617Not applicable
• Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world BehaviorTerminatedNCT03840694Not applicable
• Stage Ib Trial of mSMART With VareniclineWithdrawnNCT03069768Phase 1
• Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation ProgramTerminatedNCT02845687
• Study on Sit to Quit Phone InterventionCompletedNCT02840435Not applicable
• Stage Ib Trial of mSMART for Smoking Cessation Medication AdherenceStatus unknownNCT02635919Not applicable
• Novel Approaches to Reducing Tobacco Related HarmCompletedNCT02600273Not applicable
• The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and DependenceCompletedNCT02590393Phase 1/2
• Electronic Nicotine Delivery Systems as a Smoking Cessation TreatmentWithdrawnNCT02487953Phase 2
• Contingency Management, Quitting Smoking, and ADHDCompletedNCT02266784Phase 1
• Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx PillsCompletedNCT02072005